| Literature DB >> 29104612 |
Rafael José Maurette1, Marcos García Ejarque1, Matías Mihura1, Mariano Bregante1, Diego Bogetti1, Daniel Pirchi1.
Abstract
BACKGROUND: Laparoscopic liver resections (LLRs) have been shown to be both feasible and safe. However, no randomised control studies have been performed to date comparing results with those of the open surgery approach. MAIN AIM: To analyse LLR long-term results and compare them with a similar group of open resections in patients with colorectal carcinoma liver metastasis (CRCLM).Entities:
Keywords: colorectal cancer; laparoscopic liver surgery; liver metastases; liver surgery
Year: 2017 PMID: 29104612 PMCID: PMC5659829 DOI: 10.3332/ecancer.2017.775
Source DB: PubMed Journal: Ecancermedicalscience ISSN: 1754-6605
Demographic data in the laparoscopy group and in the open surgery group.
| Variable | Laparoscopy Group (n=18) | Open surgery group (n=22). | p = |
|---|---|---|---|
| Sex F/M | 7/11 | 7/15 | 0.641 |
| Age, median (range) | 66 (33–83) | 58.7 (33–78) | 0.059 |
| B.M.I., median (range) | 27.2 (19.6–33.2) | 26.6 (18.7–34.5) | 0.690 |
| ASA (I/II/II)I | 0/9/9 | 3/12/7 | 0.191 |
| CEA, median (range) | 3.15 (1.6–375) | 10 (1–335) | 0.236 |
| Node size in mm, median (range) | 22.5 (7–60) | 29 (12–60) | 0.0497 |
| Bilateral | 7/18 | 10/22 | 0.676 |
| Node number, median (range) | 2 (1–4) | 2.5 (1–5) | 0.168 |
| Synchronic/metachronous | 9/18 | 8/22 | 0.385 |
| Segments NOT laparoscopic | 12/18 | 12/22 | 0.436 |
S7, S8, S4A
Operative variables.
| Variable | Laparoscopy group(N=18) | Open surgery group (N=22) | p = |
|---|---|---|---|
| Hepatect. Anat/No anat/Anat+No anat | 8/8/2 | 5/12/5 | 0.301 |
| Major Hepatectomy | 4 | 7 | 0.499 |
| Associated RFA | 2 | 5 | 0.336 |
| Min. surgery time, median (range) | 245 (75–510) | 300 (165–590) | 0.0310 |
| Pringle’s manoeuvre | 10/18 | 9/22 | 0.429 |
| Min. Duration Pringle’s manoeuvre, median (range) | 36 (15–50) | 27.5 (13–50) | 0.205 |
| UGR Transfusion (n° of patients) | 3/18 | 8/22 | 0.165 |
| UGR Transfusion (n° of units), median (range) | 2 (2–6) | 2 (1–7) | 0.599 |
| Intraoperative Events | 0 | 1 | 0.265 |
| Hospital Stay | 5 (4–49) | 7 (4–73) | 0.0852 |
Only hepatectomy.
Global and specific morbidity for both groups.
| Complication | Laparoscopy group | Open surgery group | p = | |
|---|---|---|---|---|
| Pneumonia | 1 | 2 | ||
| Infection of the wound | 1 | 2 | ||
| Biliary fistula A | 2 | 1 | ||
| Abdominal abscess | 0 | 3 | ||
| Fistula B | 2 | 1 | ||
| Fistula C | 1 | 2 | ||
| Hollow Viscera Perforation | 1 | 1 | ||
| 2 | 6 | 0.234 | ||
| 5 | 4 | 0.470 | ||
| A | 2 | 1 | ||
| B | 2 | 1 | ||
| C | 1 | 2 | 0.701 | |
Percutaneous drainage was required.
International Study Group of Liver Surgery (ISGLS)
Oncological variables.
| Variable | Laparoscopy Group | Open surgery group | p = |
|---|---|---|---|
| Histology Adenocarcinoma Mucus-secreting adenocarcinoma Complete necrosis | 15 | 17 | 0.362 |
| N | 2 (1–7) | 2 (0–7) | 0.635 |
| Size of the biggest node in mm, median (range) | 26 (5–100) | 26.5 (11–64) | 0.692 |
| Histological Grade G3 | 3/18 | 1/22 | 0.310 |
| 4.5 (0–40) | 5 (1–23) | 0.726 | |
| Resection R0/R1 | 1/16 | 0/17 | 0.295 |
| N of primary tumour N0/N1/N2 | 6/8/4 | 7/13/2 | 0.461 |
| Neoadjuvant chemotherapy | 6/18 | 15/22 | 0.028 |
| Adjuvant chemotherapy | 16/18 | 14/14 | 0.492 |
G3: poorly differentiated.
Patients with RFA associated to them were not included.
Fischer
Figure 1.Free from disease survival 1, 3, and 8 years. Resections without RFA, Laparoscopy group N = 16, Open surgery N = 18.
Publication of a series of comparative cases between laparoscopy and open Surgery for liver resection in CRCLM.
| Author | Year | N° pat. | Follow-up months | RFS months | Three years RFS (%) | Five years RFS (%) | Three years | Five years GS | p = |
|---|---|---|---|---|---|---|---|---|---|
| 2009 | 60/60 | 30/33 | 47/40 | 47/40 | 35/27 | 82/70 | 64/56 | NS | |
| 2011 | 24/25 | 27/29 | NA | 63/46 | NA | 75/79 | NA | NS | |
| 2012 | 13/13 | NA | NA | NA | NA | 55/54 | 27/31 | NS | |
| 2012 | 20/20 | NA | NA | NA | 43/23 | NA | 48/46 | NS | |
| 2012 | 20/40 | NA | 9.8/10.9 | 42/18 | 42/18 | 54/65 | 54/22 | NS | |
| 2012 | 35/140 | NA | NA | 37/39 | 15/22 | 63/60 | 36/42 | NS | |
| 2013 | 30/30 | NA | NA | NA | NA | NA | NA | ||
| 2013 | 40/40 | 16/16 | 23/23 | NA | NA | 89/81 | NA | NS | |
| 2013 | 21/21 | NA | NA | 14/33 | 14/25 | 84/89 | 42/51 | NS | |
| 2014 | 57/57 | 41/54 | NA | 39/42 | 29/38 | 75/75 | 60/65 | NS | |
| 2015 | 24/24 | 24/35 | 14/24 | 29/25 | 29/18 | 55/49 | 40/39 | NS |
Follow-up in months.
Follow-up in two years.